

The Efficacy of Distant Healing: An Ongoing Four-Armed Randomized Study in Europe (EUHEALS)
Principal Investigators: H. Walach1, PhD; H. Bösch 1, Dipl. Psych.; E. Haraldsson 2, PhD; A. Marx 3, MD; H. Tomasson 4; G. Lewith, PhD 5
Affiliations: 1 Institute of Environmental Medicine and Hospital Epidemiology, University Hospital Freiburg; 2 Department of Psychology, University of Reykjavik, Iceland; 3 Institute of Clinical Epidemiology, University Hospital Basel, Switzerland; 4 Faculty of Economics & Business Administration, University of Reykjavik, Iceland; 5 Community Clinical Sciences, University of Southampton Medical School, UK
Background: Preliminary evidence suggests possible beneficial effects during distant healing. In this study, patients suffering from multiple chemical sensitivity and chronic fatigue syndrome, both of which have few effective conventional treatment options, will be offered distant healing within a formal trial.
Objective of the study: The question posed is two-fold: (1) Do patients with chronic fatigue or multiple chemical sensitivity benefit from distant healing? Is there a general, non-specific effect of healing due to expectation of healing? (2) Do patients who know that they are being treated benefit more than those who don’t? Is there a specific effect of healing, apart from the nonspecific effect of expectation?
Methods: This four-armed randomized trial will include 400 patients with self-attributed, environmental problems within the diagnostic criteria of Severe Idiopathic Chronic Fatigue, Chronic Fatigue Syndrome or Multiple Chemical Sensitivity. Patients will be recruited by specialized general practitioners and environmental clinics. They will be treated by healers distributed all over Europe, coming from various healing traditions and nationalities. Each patient will be treated by three healers. Healers will have no contact with the patients and will only be provided with the patient’s first name and a photograph. The patients will be randomized to one of four groups in a 2X2 factorial design. They will either receive (distant) healing or not, and either know or not know this decision. Primary outcome measure will be the mental health summary scale of the MOS SF-36. The measure will be taken at the beginning and at the end of a 6 month treatment or waiting period respectively.